Publications
Below you can find a list of our published research.
Below you can find a list of our published research.
7646 results
Cited 3 times since 2023 (1.8 per year) source: EuropePMC
The Journal of dermatological treatment, Volume 34, Issue 1, 1 1 2023, Pages 2254567 Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps. van der Rijst LP, van Royen-Kerkhof A, Pasmans SGMA, Schappin R, de Bruin-Weller MS, de Graaf M
Biologicals are becoming increasingly important in the therapeutic landscape of pediatric patients with moderate-to-severe atopic dermatitis (AD). Currently, dupilumab and tralokinumab are registered for the treatment of moderate-to-severe AD, and novel biologicals are expected to follow. Dupilumab was the first biological registered for AD in pediatric patients and was recently approved for patients aged six months to five years. Current and emerging biologicals may address the unmet need for e... Abstract
Cited 5 times since 2023 (3 per year) source: EuropePMC
European heart journal. Cardiovascular Imaging, Volume 25, Issue 1, 1 1 2023, Pages e33-e54 Imaging in patients with cardiovascular implantable electronic devices: part 2-imaging after device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC. Stankovic I, Voigt JU, Burri H, Muraru D, Sade LE, Haugaa KH, Lumens J, Biffi M, Dacher JN, Marsan NA, Bakelants E, Manisty C, Dweck MR, Smiseth OA, Donal E, Reviewers: This document was reviewed by members of the 2020–2022 EACVI Scientific Documents Committee:, by the 2020–2022 EACVI President:
Cardiac implantable electronic devices (CIEDs) improve quality of life and prolong survival, but there are additional considerations for cardiovascular imaging after implantation-both for standard indications and for diagnosing and guiding management of device-related complications. This clinical consensus statement (part 2) from the European Association of Cardiovascular Imaging, in collaboration with the European Heart Rhythm Association, provides comprehensive, up-to-date, and evidence-based... Abstract
Cited 2 times since 2023 (1.2 per year) source: EuropePMC
European heart journal. Cardiovascular Imaging, Volume 25, Issue 1, 1 1 2023, Pages e1-e32 Imaging in patients with cardiovascular implantable electronic devices: part 1-imaging before and during device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC. Stankovic I, Voigt JU, Burri H, Muraru D, Sade LE, Haugaa KH, Lumens J, Biffi M, Dacher JN, Marsan NA, Bakelants E, Manisty C, Dweck MR, Smiseth OA, Donal E, Reviewers: This document was reviewed by members of the 2020-2022 EACVI Scientific Documents Committee:, by the 2020–2022 EACVI President:
More than 500 000 cardiovascular implantable electronic devices (CIEDs) are implanted in the European Society of Cardiology countries each year. The role of cardiovascular imaging in patients being considered for CIED is distinctly different from imaging in CIED recipients. In the former group, imaging can help identify specific or potentially reversible causes of heart block, the underlying tissue characteristics associated with malignant arrhythmias, and the mechanical consequences of conducti... Abstract
Cited 1 times since 2023 (0.6 per year) source: EuropePMC
Liver international : official journal of the International Association for the Study of the Liver, Volume 43, Issue 12, 1 1 2023, Pages 2586-2588 Assessment of myocardial dysfunction in cirrhotic patients: Should we look at the left atrium rather than at the left ventricle? Groen RA, Ajmone Marsan N, Jukema JW, Coenraad MJ
Cited 8 times since 2023 (4.8 per year) source: EuropePMC
European heart journal. Quality of care & clinical outcomes, Volume 9, Issue 8, 1 1 2023, Pages 778-784 The impact of atrial fibrillation on prognosis in aortic stenosis. Laenens D, Stassen J, Galloo X, Ewe SH, Singh GK, Ammanullah MR, Hirasawa K, Sia CH, Butcher SC, Chew NWS, Kong WKF, Poh KK, Ding ZP, Ajmone Marsan N, Bax JJ
Background: Atrial fibrillation (AF) and aortic stenosis (AS) are both highly prevalent and often coexist. Various studies have focused on the prognostic value of AF in patients with AS, but rarely considered left ventricular (LV) diastolic function as a prognostic factor. Objective: To evaluate the prognostic impact of AF in patients with AS while correcting for LV diastolic function. Methods: Patients with first diagnosis of significant AS were selected and stratified according to history of A... Abstract
JACC. Clinical electrophysiology, Volume 9, Issue 12, 1 1 2023, Pages 2662-2663 Reply: Association of Adverse Events With the Different Diagnostic Schemes of Cardiac Sarcoidosis. Myadam R, Crawford TC, Bogun FM, Gu X, Ellenbogen KA, Jasti S, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Garlitski AC, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, De Lurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Sauer WH, Kron J, Cardiac Sarcoidosis Consortium
Cited 8 times since 2023 (4.8 per year) source: EuropePMC
Neuro-oncology, Volume 25, Issue 12, 1 1 2023, Pages 2250-2261 Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study: First results after centralization of care. Van Schaik J, Schouten-van Meeteren AYN, Vos-Kerkhof E, Janssens GO, Porro GL, Fiocco M, Bakker B, Tissing WJE, Hoving EW, van Santen HM
Background: Childhood craniopharyngioma (cCP) has excellent survival, but quality of life may be severely hampered by hypothalamic dysfunction. We aimed to evaluate treatment and hypothalamic outcomes of a Dutch cCP cohort, and evaluate the effect of centralization of care. Methods: A retrospective cohort study was performed, including cCP patients diagnosed between 2004 and 2021. Treatment characteristics and hypothalamic outcomes were evaluated and compared before and since centralization of c... Abstract
Cited 3 times since 2023 (1.8 per year) source: EuropePMC
Giornale italiano di cardiologia (2006), Volume 24, Issue 12 Suppl 1, 1 1 2023, Pages e1-e101 [2023 ESC Guidelines for the management of endocarditis]. Marsan NA, de Waha S, Bonaros N, Brida M, Burri H, Caselli S, Doenst T, Ederhy S, Erba PA, Foldager D, Fosbø EL, Kovac J, Mestres CA, Miller OI, Miro JM, Pazdernik M, Pizzi MN, Quintana E, Rasmussen TB, Ristić AD, Rodés-Cabau J, Sionis A, Zühlke LJ, ESC Scientific Document Group, Delgado V, Borger MA
Cited 15 times since 2023 (9 per year) source: EuropePMC
Nature reviews. Urology, Volume 21, Issue 4, 30 5 2023, Pages 243-251 Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System. Panebianco V, Briganti A, Boellaard TN, Catto J, Comperat E, Efstathiou J, van der Heijden AG, Giannarini G, Girometti R, Mertens L, Takeuchi M, Muglia VF, Narumi Y, Novara G, Pecoraro M, Roupret M, Sanguedolce F, Santini D, Shariat SF, Simone G, Vargas HA, Woo S, Barentsz J, Witjes JA
Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder... Abstract
Cited 2 times since 2023 (1.2 per year) source: EuropePMC
Nursing ethics, Volume 31, Issue 6, 30 5 2023, Pages 1140-1155 Effectiveness of CURA: Healthcare professionals' moral resilience and moral competences. van Schaik M, Pasman HRR, Widdershoven GA, De Snoo-Trimp J, Metselaar S
Background: Clinical ethics support instruments aim to support healthcare professionals in dealing with moral challenges in clinical practice. CURA is a relatively new instrument tailored to the wishes and needs of healthcare professionals in palliative care, especially nurses. It aims to foster their moral resilience and moral competences.Aim: To investigate the effects of using CURA on healthcare professionals regarding their Moral Resilience and Moral Competences.Design: Single group pre-/pos... Abstract
JTCVS open, Volume 17, 28 4 2023, Pages 47-54 Do postoperative hemodynamic parameters add prognostic value for mortality after surgical aortic valve replacement? Velders BJJ, Vriesendorp MD, Asch FM, Dagenais F, Lange R, Reardon MJ, Rao V, Sabik JF, Groenwold RHH, Klautz RJM
Background: Although various hemodynamic parameters to assess prosthetic performance are available, prosthesis-patient mismatch (PPM) is defined exclusively by effective orifice area (EOA) index thresholds. Adjusting for the Society of Thoracic Surgeons predicted risk of mortality (STS PROM), we aimed to explore the added value of postoperative hemodynamic parameters for the prediction of all-cause mortality at 5 years after aortic valve replacement. Methods: Data were obtained from the Pericard... Abstract
Cited 16 times since 2023 (9.6 per year) source: EuropePMC
The lancet. Gastroenterology & hepatology, Volume 9, Issue 2, 28 4 2023, Pages 110-123 The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study. de Graaf MCG, Lawton CL, Croden F, Smolinska A, Winkens B, Hesselink MAM, van Rooy G, Weegels PL, Shewry PR, Houghton LA, Witteman BJM, Keszthelyi D, Brouns FJPH, Dye L, Jonkers DMAE
Background: Many individuals without coeliac disease or wheat allergy reduce their gluten intake because they believe that gluten causes their gastrointestinal symptoms. Symptoms could be affected by negative expectancy. Therefore, we aimed to investigate the effects of expectancy versus actual gluten intake on symptoms in people with non-coeliac gluten sensitivity (NCGS). Methods: This randomised, double-blind, placebo-controlled, international, multicentre study was done at the University of L... Abstract
American journal of psychotherapy, Volume 77, Issue 1, 28 4 2023, Pages 1-6 Feasibility and Acceptability of Group Interpersonal and Social Rhythm Therapy for Recurrent Mood Disorders: A Pilot Study. Orhan M, Korten N, Mans N, van Schaik D, Kupka R, Stek M, Steenhuis D, van Dijk M, Swartz HA, van Oppen P, Dols A
Objective: Interpersonal and social rhythm therapy (IPSRT) was developed to empower patients with mood disorders by stabilizing underlying disturbances in circadian rhythms and by using strategies from interpersonal psychotherapy. Group IPSRT has not been studied with a transdiagnostic sample of patients across the life span with either major depressive disorder or bipolar disorder. Methods: Thirty-eight outpatients, ages 26-80, with major depressive disorder or bipolar disorder in any mood stat... Abstract
Cited 2 times since 2023 (1.2 per year) source: EuropePMC
PLoS computational biology, Volume 19, Issue 11, 27 4 2023, Pages e1010928 A Bayesian inference method to estimate transmission trees with multiple introductions; applied to SARS-CoV-2 in Dutch mink farms. Van der Roest BR, Bootsma MCJ, Fischer EAJ, Klinkenberg D, Kretzschmar MEE
Knowledge of who infected whom during an outbreak of an infectious disease is important to determine risk factors for transmission and to design effective control measures. Both whole-genome sequencing of pathogens and epidemiological data provide useful information about the transmission events and underlying processes. Existing models to infer transmission trees usually assume that the pathogen is introduced only once from outside into the population of interest. However, this is not always tr... Abstract
Cited 1 times since 2023 (0.6 per year) source: EuropePMC
Cancer treatment reviews, Volume 122, 27 4 2023, Pages 102662 Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors. de Joode K, Heersche N, Basak EA, Bins S, van der Veldt AAM, van Schaik RHN, Mathijssen RHJ
The development of immune checkpoint inhibitors (ICIs) has a tremendous effect on the treatment options for multiple types of cancer. Nonetheless, there is a large interpatient variability in response, survival, and the development of immune-related adverse events (irAEs). Pharmacogenetics is the general term for germline genetic variations, which may cause the observed interindividual differences in response or toxicity to treatment. These genetic variations can either be single-nucleotide poly... Abstract
Cited 2 times since 2023 (1.2 per year) source: EuropePMC
Multiple sclerosis and related disorders, Volume 81, 26 4 2023, Pages 105149 Optic neuritis in Turkish children and adolescents: A multicenter retrospective study. Direk MÇ, Besen Ş, Öncel İ, Günbey C, Özdoğan O, Orgun LT, Sahin S, Cansu A, Yıldız N, Kanmaz S, Yılmaz S, Tekgül H, Türkdoğan D, Ünver O, Thomas GÖ, Başıbüyük S, Yılmaz D, Kurt AN, Gültutan P, Özsoy Ö, Yiş U, Kurul SH, Güngör S, Özgör B, Karadağ M, Dündar NO, Gençpınar P, Bildik O, Orak SA, Kabur ÇÇ, Kara B, Karaca Ö, Canpolat M, Gümüş H, Per H, Yılmaz Ü, Karaoğlu P, Ersoy Ö, Tosun A, Öztürk SB, Yüksel D, Atasoy E, Gücüyener K, Yıldırım M, Bektaş Ö, Çavuşoğlu D, Yarar Ç, Güngör O, Mert GG, Sarıgeçili E, Edizer S, Çetin İD, Aydın S, Diler B, Özdemir AA, Erol İ, Okuyaz Ç, Anlar B
Background: Various etiologies may underlie optic neuritis, including autoantibody-mediated disorders described in the last decade. We re-examined demographic, clinical, laboratory features and prognostic factors in pediatric patients with autoimmune optic neuritis according to current knowledge. Methods: Cases of pediatric ON from 27 centers in Türkiye diagnosed between 2009 and 2022 were included for retrospective evaluation. Results: The study included 279 patients, 174 females and 105 males,... Abstract
Cited 5 times since 2023 (3 per year) source: EuropePMC
The Journal of investigative dermatology, Volume 144, Issue 6, 25 4 2023, Pages 1378-1388.e1 Characterization of Patient-Derived GNAQ Mutated Endothelial Cells from Capillary Malformations. Langbroek GB, Stor MLE, Janssen V, de Haan A, Horbach SER, Graupera M, van Noesel CJM, van der Horst CMAM, Wolkerstorfer A, Huveneers S
Capillary malformations (CM) (port-wine stains) are congenital skin lesions that are characterized by dilated capillaries and postcapillary venules. CMs are caused by altered functioning of the vascular endothelium. Somatic genetic mutations have predominantly been identified in the endothelial cells of CMs, providing an opportunity for the development of targeted therapies. However, there is currently limited in-depth mechanistic insight into the pathophysiology and a lack of preclinical resear... Abstract
Cited 8 times since 2023 (4.8 per year) source: EuropePMC
Soft matter, Volume 19, Issue 45, 22 4 2023, Pages 8832-8848 Hydrophobically modified complex coacervates for designing aqueous pressure-sensitive adhesives. van Westerveld L, Es Sayed J, de Graaf M, Hofman AH, Kamperman M, Parisi D
The rheology of complex coacervates can be elegantly tuned via the design and control of specific non-covalent hydrophobic interactions between the complexed polymer chains. The well-controlled balance between elasticity and energy dissipation makes complex coacervates perfect candidates for pressure-sensitive adhesives (PSAs). In this work, the polyanion poly(3-sulfopropyl methacrylate) (PSPMA) and the polycation quaternized poly(4-vinylpyridine) (QP4VP) were used to prepare complex coacervates... Abstract
Cited 2 times since 2023 (1.2 per year) source: EuropePMC
The Journal of cardiovascular surgery, Volume 65, Issue 3, 21 3 2023, Pages 256-264 The association between sarcopenia and adverse outcomes after complex endovascular aortic repair. Warmerdam BW, van Rijswijk CS, Droop A, Lucassen CJ, Hamming JF, van Schaik J, van der Vorst JR
Background: Sarcopenia is identified as a predictive factor for adverse outcomes after complex endovascular aortic repair (complex EVAR). Consensus on preferred parameters for sarcopenia is not yet reached. The current study compares three CT-assessed parameters on their association with adverse outcomes after complex EVAR. Methods: This was a single-center retrospective cohort study. Psoas Muscle Index (PMI), Skeletal Muscle Index (SMI), and lean psoas muscle area (LPMA) were examined by CT-seg... Abstract
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Volume 169, 21 3 2023, Pages 115890 A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Buck SAJ, Meertens M, van Ooijen FMF, Oomen-de Hoop E, de Jonge E, Coenen MJH, Bergman AM, Koolen SLW, de Wit R, Huitema ADR, van Schaik RHN, Mathijssen RHJ
Extragonadal androgens play a pivotal role in prostate cancer disease progression on androgen receptor signaling inhibitors (ARSi), including abiraterone and enzalutamide. We aimed to investigate if germline variants in genes involved in extragonadal androgen synthesis contribute to resistance to ARSi and may predict clinical outcomes on ARSi. We included ARSi naive metastatic prostate cancer patients treated with abiraterone or enzalutamide and determined 18 germline variants in six genes invol... Abstract